Laurent Azoulay

epidemiology

H指数:54

被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The association between pre-existing type 2 diabetes on cancer-related and all-cause mortality among women with breast cancer

女性乳腺癌患者中，2型糖尿病与癌症相关死亡和全因死亡的关联性

Breast Cancer Research and Treatment

IF3

2026-02-090

PRE

Incretin-Based Drugs and the Risk of Dementia Among Patients with Type 2 Diabetes

基于肠促胰素药物与2型糖尿病患者痴呆风险

Drug Safety

IF3.8

2025-10-220

PRE

Metformin to treat breast cancer: An application of the prevalent new-user design for observational studies with no active comparator

二甲双胍治疗乳腺癌：一种无活性对照观察性研究中常见的新用户设计应用

Journal of Clinical Epidemiology

IF5.2

2025-06-250

Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study

胰高血糖素样肽-1受体激动剂与2型糖尿病患者自杀风险：活性对照、新使用者队列研究

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2025-02-260

PRE

Association between use of sodium-glucose co-transporter-2 inhibitor and the risk of incident dementia: a population-based cohort study

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2025-01-210

OAAI

Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Suicide and Self-Harm among Patients with Type 2 Diabetes

DIABETES

IF7.5

2024-06-210

PRE

Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study

DRUG SAFETY

IF3.8

2024-05-083

PRE

Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2024-04-2522

OAAI

Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: A population-based cohort study

使用5-α 还原酶抑制剂与良性前列腺增生男性患胃肠癌的风险: 一项基于人群的队列研究

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2024-03-301

Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2024-03-131

OAAI

Immunosuppression and cancer risk in kidney transplant recipients: A retrospective cohort study

肾移植受者的免疫抑制和癌症风险: 一项回顾性队列研究

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2024-02-123

OAAI

Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer's disease: A population-based nested case-control study

ALZHEIMERS & DEMENTIA

IF11.1

2023-12-135

Sodium-glucose Cotransporter-2 Inhibitors and Risk of Hepatocellular Carcinoma Among Patients With Type 2 Diabetes

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IF12

2023-12-014

PRE

Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2023-11-105

OAAI

Glucagon like peptide-1 receptor agonists and the risk of skin cancer among patients with type 2 diabetes: Population-based cohort study

胰高血糖素样肽-1受体激动剂与2型糖尿病患者皮肤癌风险: 基于人群的队列研究

DIABETIC MEDICINE

IF3.4

2023-11-103

OAAI

Response to Magnaterra et al's unveiling hydrochlorothiazide: Skin cancer risk and hidden interactions

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2023-11-010

Thiazide Diuretics and Risk of Colorectal Cancer: A Population-Based Cohort Study

AMERICAN JOURNAL OF EPIDEMIOLOGY

IF4.8

2023-08-110

PRE

Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2023-08-016

PRE

The application of lag times in cancer pharmacoepidemiology: a narrative review

ANNALS OF EPIDEMIOLOGY

IF3

2023-08-0117

OAAI

Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom

DIABETES OBESITY & METABOLISM

IF5.7

2023-07-0319

PRE

Laurent Azoulay

个人简介

教育背景

工作经历

荣誉奖项

研究方向